Revenue: The sum of all revenue fields included for a company's operating activities.
Dare Bioscience, Inc. (DARE) had Revenue of $0.01M for the most recently reported fiscal year, ending 2024-12-31.
Income Statement Financials | |
Revenue |
$0.01M |
$-4.05M |
|
-- |
|
$0.01M |
|
$23.46M |
|
$-23.45M |
|
$19.40M |
|
$-4.05M |
|
$-24.43M |
|
$-4.05M |
|
$-4.05M |
|
$-4.05M |
|
$-24.43M |
|
$-23.45M |
|
$-23.41M |
|
8.50M |
|
8.50M |
|
$-0.48 |
|
$-0.48 |
|
Balance Sheet Financials | |
$18.45M |
|
$1.34M |
|
$3.65M |
|
$22.10M |
|
$21.61M |
|
-- |
|
$6.50M |
|
$28.11M |
|
$-6.01M |
|
$-6.01M |
|
$-6.01M |
|
8.70M |
|
Cash Flow Statement Financials | |
$5.39M |
|
$-0.57M |
|
$0.43M |
|
$10.81M |
|
$16.00M |
|
$5.19M |
|
$2.20M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
0.85 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-239692.20% |
|
-239692.20% |
|
-239259.60% |
|
-41430.89% |
|
-41430.89% |
|
$4.82M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.04 |
|
8579.66 |
|
67.42% |
|
67.42% |
|
-18.34% |
|
67.42% |
|
$-0.69 |
|
$0.57 |
|
$0.63 |